Stay updated on Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Sign up to get notified when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.

Latest updates to the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.4.3 and removed related topics including 'Multiple myeloma', 'MedlinePlus Genetics', and 'Revision: v3.4.2'.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded related topics sections for Multiple Myeloma and MedlinePlus Genetics on the page.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded 'Revision: v3.4.2' and removed 'Revision: v3.4.1' in the page metadata.SummaryDifference0.0%

- Check38 days agoChange DetectedThis update appears to be metadata changes only (new revision v3.4.1 and updated timestamps); no core study data or eligibility were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedGlossary display is now shown and new QC metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) appears on the page. The related topics section was removed, including the 'Multiple Myeloma' entry and 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page adds 'Multiple myeloma' as a related topic, includes a MedlinePlus Genetics link, and updates the revision to v3.3.4 (replacing v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.